237 related articles for article (PubMed ID: 7735919)
41. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
42. The requirement for macrophage-lymphocyte interaction in T lymphocyte proliferation induced by generation of aldehydes on cell membranes.
Greineder DK; Rosenthal AS
J Immunol; 1975 Oct; 115(4):932-8. PubMed ID: 170338
[TBL] [Abstract][Full Text] [Related]
43. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
Novogrodsky A
J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
[TBL] [Abstract][Full Text] [Related]
44. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli].
Karitskaia IA; Aksenov ND; Zenin VV; Khaĭdukova AL; Marakhova II
Tsitologiia; 2006; 48(1):42-9. PubMed ID: 16568834
[TBL] [Abstract][Full Text] [Related]
45. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients.
Hamurcu Z; Demirtas H; Patiroglu T; Kumandas S; Imamoglu N; Ozkul Y; Donmez-Altuntas H
Cytometry B Clin Cytom; 2007 Jan; 72(1):43-8. PubMed ID: 17041944
[TBL] [Abstract][Full Text] [Related]
46. Accessory cell-independent activation of T cells by oxidized red blood cells plus polyethylene glycol.
Ocklind G; Lindahl-Kiessling K
Immunobiology; 1987 Dec; 176(1-2):167-76. PubMed ID: 3502338
[TBL] [Abstract][Full Text] [Related]
47. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
[TBL] [Abstract][Full Text] [Related]
48. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
49. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
[TBL] [Abstract][Full Text] [Related]
50. Detection of memory cells by chemical modification of the lymphocyte cell surface.
Stenzel KH; Suthanthiran M; Rubin AL; Novogrodsky A
Proc Eur Dial Transplant Assoc; 1979; 16():437-41. PubMed ID: 162003
[TBL] [Abstract][Full Text] [Related]
51. Mononuclear cells in sickle cell disease: subpopulations and in vitro response to mitogens.
Hendriks J; De Ceulaer K; Williams E; Serjeant GR
J Clin Lab Immunol; 1984 Mar; 13(3):129-32. PubMed ID: 6609238
[TBL] [Abstract][Full Text] [Related]
52. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
53. Cellular immunity in newborn infants and children: stimulation of lymphocyte protein synthesis as a measure of immune competence.
Schechter B; Handzel ZT; Altman Y; Nir E; Levin S
Clin Exp Immunol; 1977 Mar; 27(3):478-84. PubMed ID: 862234
[TBL] [Abstract][Full Text] [Related]
54. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
[TBL] [Abstract][Full Text] [Related]
55. Characterization of responding cells in oxidative mitogen stimulation. II. Identification of an Ia-bearing adherent accessory cell.
Phillips ML; Parker JW; Frelinger JA; O'Brien RL
J Immunol; 1980 Jun; 124(6):2700-7. PubMed ID: 7373043
[TBL] [Abstract][Full Text] [Related]
56. Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans.
Crary B; Borysenko M; Sutherland DC; Kutz I; Borysenko JZ; Benson H
J Immunol; 1983 Feb; 130(2):694-7. PubMed ID: 6681539
[TBL] [Abstract][Full Text] [Related]
57. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
Guss RB; McCulley JP
Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
[TBL] [Abstract][Full Text] [Related]
58. Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders.
Prince HE; John JK
Diagn Immunol; 1986; 4(6):306-11. PubMed ID: 3102150
[TBL] [Abstract][Full Text] [Related]
59. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation.
Greer WL; Higgins E; Sutherland DR; Novogrodsky A; Brockhausen I; Peacocke M; Rubin LA; Baker M; Dennis JW; Siminovitch KA
Biochem Cell Biol; 1989 Sep; 67(9):503-9. PubMed ID: 2803729
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of T-cell response to PWM by neuraminidase-treated non-T cells.
Sakano T
Immunology; 1980 Feb; 39(2):203-7. PubMed ID: 6966605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
